Loss of ERbeta expression as a common step in estrogen-dependent tumor progression - Wikidata - wikimedia - TriplyDB

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

http://www.wikidata.org/entity/Q35888377

about

Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells Potential action of androstenedione on the proliferation and apoptosis of stromal endometrial cells Hormones in Dairy Foods and Their Impact on Public Health - A Narrative Review Article Estrogen, male dominance and esophageal adenocarcinoma: is there a link?Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?Sustained proliferation in cancer: Mechanisms and novel therapeutic targets The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer ERbeta in breast cancer--onlooker, passive player, or active protector?The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells The potential health effects of dietary phytoestrogens HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb Probing the link between oestrogen receptors and oesophageal cancer.Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer IGF-1 gene expression is differentially regulated by estrogen receptors α and β in mouse endometrial stromal cells and ovarian granulosa cells.Estrogens and the pathophysiology of the biliary tree Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.Effect of estradiol on proliferation and differentiation of side population stem/progenitor cells from murine endometrium.Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Enhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice.Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.The role of estrogen receptor β in prostate cancer.Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.A screening cascade to identify ERβ ligands.The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?Role of sex hormones in the modulation of cholangiocyte function.Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.

P2860

Q24315496-7A761416-5564-4254-960B-C6F17C1B25B5 Q24801856-2E53FE81-A98B-4C36-A840-05CC54D0999F Q26799965-DD1484D3-07ED-4100-99C7-04A463F3ACEC Q27023016-6416105E-6A0F-4C10-ADD1-AE40A45689E1 Q27319512-FF875D7E-EC49-44FD-8AE3-0EEBF2215154 Q28087571-71991C3A-FA47-4E3E-B443-EA137BBBF96C Q28109453-A12D874D-E3E3-4114-BA72-3E88F62DB6EF Q28388405-5AAF5D68-056F-4421-B1A0-BC23928DBF93 Q28390036-69A283C1-B89A-4450-BDE0-D6174601D84F Q28396388-C75830B9-FB27-4EA1-8574-386885D80E6B Q28397662-F0469EB3-3697-4814-9B22-63A564DB120F Q30438399-076F4C9B-C77A-4D3E-A700-2C35E714F98F Q30473787-2F9C8157-28E0-475E-AD98-44F19D01B41E Q33254067-AB778CC2-37E0-4E1C-91A0-161EC646D878 Q33633056-A6E4FE05-CBCC-41A5-8572-67C291269FD8 Q33638946-954C3FF1-8F90-4E08-9162-7C551314736A Q33651509-7F8424E5-3A46-4C89-A171-07819B1F1496 Q33676455-3B456C9A-1ED7-4806-870A-AB71910AE0B9 Q33702169-768845E0-FFCE-47D7-8400-FA0C78AF4D19 Q33702570-A597C2EA-83A8-44BB-B52E-A61F7D5FAAF6 Q33833367-92C6672C-6F26-4745-8E1B-2DA98EE0D0C3 Q33858037-87CDDA92-DB3F-42F6-BC6A-686B69B69D7D Q33866800-24195A30-3A8B-4BB2-AD53-BA4D5529FC8C Q33932856-E0F0BE6A-A5F5-47F8-AFA8-DFE61576910F Q33975544-273733B7-06AC-4AC9-96E3-38A5BFFCF5CF Q34014559-C40CF7F1-3303-49E5-99F3-45709D3545FA Q34103959-D2D09A67-4499-49F4-B9ED-4BE7DE90E7A8 Q34106472-33A3FE73-75DA-4E66-BD7D-991E1B806EAB Q34137246-8DB9CB1A-038F-4AD8-B452-E71BDC34120A Q34137865-8C0D0204-5A21-4FE9-8ED9-066369ACBBC6 Q34324609-B3209502-B06C-4A5B-B070-22D0AECC45D4 Q34416254-BA8A7719-D0D2-47EC-8992-DA49E8BB1BC7 Q34454890-A112D5AE-A21B-4B86-B3AC-EA3A87AC01CB Q34486859-66CF0F62-F969-4FEF-8286-B151252A98E3 Q34497901-DC0AA123-5E0B-4F32-8D21-5FF55D5B6F9E Q34564793-07E7EFF2-41B4-47DF-9E59-26DA9901AA22 Q34932849-33AEAFE5-F933-4684-A249-7C9BAAB91055 Q34992322-D7622BF5-23E3-4DF0-AB3B-FD76D61AA40C Q35222052-36BE079E-4F25-4037-BB53-9CC900EBD8A2 Q35534361-BDD29463-6F5E-4779-9F38-6D2A296CE754

P2860

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

http://www.wikidata.org/entity/Q35888377

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

@ast

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

@en

type

label

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

@ast

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

@en

prefLabel

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

@ast

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

@en

P1433

Q35888377-D81DB896-40AA-47FD-967B-A130B2EDCDA1

P1476

Q35888377-08E467AE-56F9-4453-9262-AEEDF86D9DB4

P2093

Q35888377-5F9661FD-EC2A-4C70-B110-CAB19C17309E

Q35888377-AA8C46E4-F783-4C71-8B1D-AE7C403D9A0E

Q35888377-C15BA02E-FF88-429A-A932-49D9DAA20102

Q35888377-D0D7A90E-6290-4AEE-9319-8CB896A52BBA

P2860

Q35888377-047F5B52-E657-4257-9CE1-A343AE346A3F

Q35888377-086C1B12-F688-4DE1-BA9D-64F5FD6FABC4

Q35888377-0DD599F0-5952-433A-ADC9-BF4C04E29946

Q35888377-11A35CC2-EE00-4955-8ABC-070EA2EDF696

Q35888377-11B503B8-4A03-4A62-B1A0-5F420CE6B17D

Q35888377-1406C255-6341-4756-B9C9-729B2D406EB2

Q35888377-1769D8DC-BC92-48A5-AF9D-2A7C8B6BEA90

Q35888377-191C2C9B-E7CD-48AB-B34E-626F4BF4071D

Q35888377-1A0C1B09-BCD9-4F70-8EE5-80FC22FB0834

Q35888377-1A13195D-2DDC-4849-B705-C8D76178558C

P304

Q35888377-5D22C85F-4C7D-40C1-9EA7-95EE98FE31CA

P31

Q35888377-39A25D43-D6CA-40FF-9D98-DCC2CB1D27EB

P356

Q35888377-6E06D6C3-A132-438C-9447-12C960C2158F

P433

Q35888377-D1E11F82-9918-4D89-B73C-E0D83B4809C7

P478

Q35888377-E6B8790F-CA39-487A-96BB-2A652DD384F7

P50

Q35888377-ED9A9D8C-4883-4B1C-8304-C8E6AC0AB21C

P577

Q35888377-86042234-110F-48C2-AD68-3A7C61DBF303

P5875

Q35888377-DF6130A7-755B-4281-86D1-711E0E36159D

P698

Q35888377-295CDA2F-BBA8-44D1-B240-981962FCD1C4

P932

Q35888377-97B4801B-FC37-460F-9A8B-9CB96053C2F8

P356

P1433

Endocrine-related cancer

P1476

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

@en

P2093

A Bardin

http://www.w3.org/2001/XMLSchema#string

F Vignon

http://www.w3.org/2001/XMLSchema#string

N Boulle

http://www.w3.org/2001/XMLSchema#string

P Pujol

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements

Cloning and characterization of human estrogen receptor beta isoforms

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

ER beta: identification and characterization of a novel human estrogen receptor

Functional synergy between the transcription factor Sp1 and the estrogen receptor

RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2

TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta

Cloning of a novel receptor expressed in rat prostate and ovary

P304

537-551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1677/ERC.1.00800

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Gwendal Lazennec

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237604772

http://www.w3.org/2001/XMLSchema#string

P698

15369453

http://www.w3.org/2001/XMLSchema#string

P932

2072930

http://www.w3.org/2001/XMLSchema#string